drugset / Trial / NCT02071316
The Use of Hexacapron in Upper Gastrointestinal Bleeding
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to conduct a randomized control trial, double-blind study to compare Hexacapron with standard of care treatment to standard of care alone to evaluate the efficacy of adding effect of Hexacapron to standard therapy by decreasing the episodes of rebleeding and mortality in patient with upper gastrointestinal bleeding.
Timeline
- Start
- 2014-04
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hexacapron | Unknown | 6 g | Intravenous |
| Comparator | Esomeprazole | Small molecule | 8 mg | Intravenous |
Indications
No indication recorded.